| 1 |
33973354 | The cellular function and molecular mechanism of formaldehyde in cardiovascular disease and heart development. | 2021 Jun |
2 |
| 2 |
27802225 | Urine Formaldehyde Predicts Cognitive Impairment in Post-Stroke Dementia and Alzheimer's Disease. | 2017 |
2 |
| 3 |
18845121 | A fluorometric high-performance liquid chromatography procedure for simultaneous determination of methylamine and aminoacetone in blood and tissues. | 2009 Jan 1 |
2 |
| 4 |
17401529 | Effect of aldehydes derived from oxidative deamination and oxidative stress on beta-amyloid aggregation; pathological implications to Alzheimer's disease. | 2007 |
2 |
| 5 |
17596537 | Evidence for in vivo scavenging by aminoguanidine of formaldehyde produced via semicarbazide-sensitive amine oxidase-mediated deamination. | 2007 Sep |
2 |
| 6 |
17074066 | Potential inplications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis. | 2006 Dec |
2 |
| 7 |
15128865 | Protein cross-linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine. | 2004 Sep |
5 |
| 8 |
12135815 | Serum semicarbazide-sensitive amine oxidase (SSAO) activity is an independent marker of carotid atherosclerosis. | 2002 Sep |
1 |
| 9 |
11266660 | 2-Bromoethylamine as a potent selective suicide inhibitor for semicarbazide-sensitive amine oxidase. | 2001 Mar 15 |
2 |
| 10 |
11461168 | Involvement of cerebrovascular semicarbazide-sensitive amine oxidase in the pathogenesis of Alzheimer's disease and vascular dementia. | 2001 Aug |
4 |
| 11 |
10859677 | Potential cytotoxic effect of chronic administration of creatine, a nutrition supplement to augment athletic performance. | 2000 May |
2 |
| 12 |
9920154 | Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride. | 1999 Jan |
1 |
| 13 |
10892891 | Determination of human serum semicarbazide-sensitive amine oxidase activity: a possible clinical marker of atherosclerosis. | 1999 Oct-Dec |
1 |
| 14 |
9572061 | Potential therapeutic value of drugs inhibiting semicarbazide-sensitive amine oxidase: vascular cytoprotection in diabetes mellitus. | 1998 Feb |
1 |
| 15 |
9131641 | Formation of formaldehyde from adrenaline in vivo; a potential risk factor for stress-related angiopathy. | 1997 May |
2 |
| 16 |
9503571 | [Effect of activity of semicarbazide-sensitive aminooxidases and cellular glutathione on the cytotoxic effect of allylamine, acrolein, and formaldehyde in human cultured endothelial cells]. | 1997 Nov-Dec |
1 |
| 17 |
8920635 | Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: biochemical, pharmacological and toxicological aspects. | 1996 Mar |
1 |
| 18 |
8584666 | Substrate-specificity of mammalian tissue-bound semicarbazide-sensitive amine oxidase. | 1995 |
1 |
| 19 |
8584667 | Some aspects of the pathophysiology of semicarbazide-sensitive amine oxidase enzymes. | 1995 |
1 |
| 20 |
7931255 | Properties of mammalian tissue-bound semicarbazide-sensitive amine oxidase: possible clues to its physiological function? | 1994 |
1 |
| 21 |
7931256 | Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; pharmacological implications. | 1994 |
1 |